Literature DB >> 184913

Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.).

J Lemerle, P A Voute, M F Tournade, J F Delemarre, B Jereb, L Ahstrom, R Flamant, R Gerard-Marchant.   

Abstract

The preliminary results of a controlled clinical trial organized by the S.I.O.P. of radiotherapy and chemotherapy in patients with nephroblastoma are presented. Forty-two centers have participated. Between September 1971 and October 1974, 398 patients were registered; 195 were eligible for the trial and were randomized. The remaining 203 patients were excluded from the trial, but were followed in the same way as the patients in the trial. The results were evaluated in terms of recurrence-free survival rate and survival rate. Results in patients who received preoperative and postoperative radiotherapy (group A, 73 patients) were compared with the results in patients who recieved only postoperative radiotherapy (group B, 64 patients). The tumor ruptured at surgery in three patients of group A, and in 20 patients of group B, a difference that is statistically significant. No significant difference in survival and recurrence-free survival between groups A and B is observed at present. Results in patients treated with a single course of actinomycin D (group I, 80 patients) were compared with the results in patients treated with multiple courses (group II, 80 patients). At present, no significant difference is found between the two groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184913     DOI: 10.1002/1097-0142(197608)38:2<647::aid-cncr2820380204>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Wilms tumor: what's new?

Authors:  Tomás Acha García; Carlota Calvo Escribano; José Alfaro Gutiérrez; Paloma Galarón García; Mercedes Guibelalde del Castillo
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405

Review 2.  Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials?

Authors:  Chris Mitchell
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

3.  The surgical treatment of Wilms' tumor: results of the National Wilms' Tumor Study.

Authors:  L L Leape; N E Breslow; H C Bishop
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

4.  Treatment of Wilms' tumor in children.

Authors:  D G Johnson
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

5.  Massive Wilms' tumor: sonographic demonstration of therapeutic response without alteration in size.

Authors:  H Shimizu; N Jaffe; F Eftekhari
Journal:  Pediatr Radiol       Date:  1987

6.  Management of Wilms' tumor and neuroblastoma.

Authors:  P Mehta; T Vats
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

Review 7.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 8.  Wilms' tumour. Optimal treatment strategies.

Authors:  K Suryanarayan; N Marina
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

9.  Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.

Authors:  John A Kalapurakal; Sierra M Li; Norman E Breslow; J Bruce Beckwith; Michael L Ritchey; Robert C Shamberger; Gerald M Haase; Patrick R M Thomas; Paul Grundy; Daniel M Green; Giulio J D'Angio
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

10.  Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4.

Authors:  Norman E Breslow; J Bruce Beckwith; Gerald M Haase; John A Kalapurakal; Michael L Ritchey; Robert C Shamberger; Patrick R M Thomas; Giulio J D'Angio; Daniel M Green
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-20       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.